Fig. 4From: Therapeutic effect of berberine on TDP-43-related pathogenesis in FTLD and ALSThe autophagy activation marker LC3-II is significantly increased in berberine-treated cells. a N2a cells were transfected with GFP-TDP-25. After 6 h transfection, N2a cells were treated with different dose of berberine for another 24 h, and then stained with anti-LC3-II (red) in immunofluorescence assay. The nuclei were stained with DAPI (blue). b Data are presented as mean ± s.e.m. of three independent experiments ***P < 0.005 (Student’s t-test compared with the control)Back to article page